Intravenous immunoglobulin therapy for Miller Fisher syndrome
about
Fisher syndrome: clinical features, immunopathogenesis and managementGuillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosisGuillain-Barré syndrome and variantsTreatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disordersPast, present and future therapeutics for cerebellar ataxias.Treatment guidelines for Guillain-Barré Syndrome.Miller Fisher syndrome mimicking ocular myasthenia gravis.Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.Plasmapheresis for neurological disorders.Therapeutic Plasma Exchange in Neurologic Diseases: An Experience with 91 Patients in Seven Years.Guillain-Barré syndrome: a review.Familial Miller Fisher syndrome.The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action.Indications and safety of intravenous and subcutaneous immunoglobulin therapy.Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings.Ocular neuropathy in peripheral neuropathies.Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment.Pupillary Involvement in Miller Fisher Syndrome.Acute bilateral ophthalmoparesis with pupilary areflexical mydriasis in miller-fisher syndrome treated with intravenous immunoglobulin.The effectiveness of immunomodulating treatment on Miller Fisher syndrome: a retrospective analysis of 65 Chinese patients.A pediatric case of Miller Fisher syndrome with central involvement.Bulbar paralysis associated with Miller-Fisher syndrome and its overlaps in Chinese patients.Unilateral Oculomotor Nerve Palsy Following Campylobacter Infection: A Mild Form of Miller Fisher Syndrome without Ataxia.
P2860
Q22241475-2F780628-C477-472D-A15B-DD379A2AFC34Q22251013-52C01516-4AA0-4A4F-A8B8-566FD690D560Q22252353-4EC0F865-58EE-4E3E-A435-0BBA45EA7E18Q24246272-0C13842A-89A1-469D-BE11-62C721564B12Q33836935-29694FD7-3541-4533-92EE-22D0DDB7055FQ35152989-CBC0A630-7893-4D66-BA94-3443FDF2B9B2Q36451078-D49E0D8D-58B5-4E16-94E2-82DA8B38FD01Q37535345-33B58128-58D1-4078-978A-76C00DF125CAQ37600865-110AA073-F8C3-490A-8213-C11AA1908AD9Q37725863-3C9FBB13-E009-41B5-A4FA-3BD773B34F7CQ37790256-AB97351F-00DB-4F7A-A015-15E72E792BE7Q37843058-9A36267B-C671-46C4-9CFF-ECB2A6A82270Q37862736-6A7E4F61-CA89-4878-AECF-2F261B9D6F59Q37877259-A8B96F82-1CB7-4F15-84A2-D349CC68BF3EQ37883488-D37054B7-96BE-4AC6-857A-1A4289BC7C18Q38051277-310A267D-71A5-4875-A5D4-A6879D915B4DQ38862736-B015EE7D-7316-4B72-AFD6-10F130793130Q38977853-F4DDDC33-FC3C-4537-9ED8-998BECF93D41Q41950466-3E154A1D-5907-46BC-A642-156ADF33E9AAQ43859486-EC419515-3D4E-44F3-83E9-FDFD5FFCE602Q44040655-44E52061-8B59-40C9-AFB1-C578518C5D9EQ47417891-44E23306-E8FE-4CB2-9D40-9688A59944D5Q49778092-BFB88DAA-4D0C-474C-B850-26BA87DC1489
P2860
Intravenous immunoglobulin therapy for Miller Fisher syndrome
description
im April 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2007
@uk
name
Intravenous immunoglobulin therapy for Miller Fisher syndrome
@en
Intravenous immunoglobulin therapy for Miller Fisher syndrome
@nl
type
label
Intravenous immunoglobulin therapy for Miller Fisher syndrome
@en
Intravenous immunoglobulin therapy for Miller Fisher syndrome
@nl
prefLabel
Intravenous immunoglobulin therapy for Miller Fisher syndrome
@en
Intravenous immunoglobulin therapy for Miller Fisher syndrome
@nl
P2093
P1433
P1476
Intravenous immunoglobulin therapy for Miller Fisher syndrome
@en
P2093
P304
P356
10.1212/01.WNL.0000258673.31824.61
P407
P577
2007-04-02T00:00:00Z